Equities
Health CarePharmaceuticals & Biotechnology
  • Price (GBX)18.70
  • Today's Change0.40 / 2.19%
  • Shares traded5.62k
  • 1 Year change-74.21%
  • Beta0.4554
Data delayed at least 20 minutes, as of May 29 2020 09:08 BST.
More ▼

Key statistics

As of last trade, Mereo BioPharma Group plc (MPH:LSE) traded at 18.70, 43.85% above the 52 week low of 13.00 set on Mar 24, 2020.
52-week range
Today
13.00Mar 24 202082.99May 30 2019
Open18.30
High18.70
Low18.70
Bid17.60
Offer19.00
Previous close18.30
Average volume644.18k
Shares outstanding124.51m
Free float103.99m
P/E (TTM)--
Market cap22.78m GBP
EPS (TTM)-0.4313
GBP
Data delayed at least 20 minutes, as of May 29 2020 09:08 BST.
More ▼

Investors Chronicle View

The last IC recommendation on Mereo BioPharma Group plc shares was Sell at 305.00 on 09 Aug 2017Read the full article

Board of Directors

1/7

Dr. Denise Scots-Knight, CEO and Co-Founder

2/7

Richard Jones, CFO

3/7

Charles Sermon, GC and Co-Founder

4/7

Dr. Alastair MacKinnon, CMO and Co-Founder

5/7

John Richard, Head of Corporate Development and Co-Founder

6/7

Wills Hughes-Wilson, Head of Patient Access & Commercial Planning

7/7

Jill Henrich, US, Site Head; SVP Regulatory Affairs

Contact

Mereo BioPharma Group plc
1 Cavendish Place
London
W1G 0QF
United Kingdom

T: +44 (0)333 023 7300
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.